A detailed history of Natixis Advisors, L.P. transactions in Penumbra Inc stock. As of the latest transaction made, Natixis Advisors, L.P. holds 27,725 shares of PEN stock, worth $6.66 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
27,725
Previous 19,020 45.77%
Holding current value
$6.66 Million
Previous $3.42 Million 57.38%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$163.64 - $210.12 $1.42 Million - $1.83 Million
8,705 Added 45.77%
27,725 $5.39 Million
Q2 2024

Aug 01, 2024

BUY
$172.27 - $223.95 $3.28 Million - $4.26 Million
19,020 New
19,020 $3.42 Million

Others Institutions Holding PEN

About Penumbra Inc


  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $9.11B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track This Portfolio

Track Natixis Advisors, L.P. Portfolio

Follow Natixis Advisors, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Natixis Advisors, L.P. with notifications on news.